Spero Therapeutics, Inc. Intellectual Property Contracts & Agreements

11 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment 4 to Exclusive License Agreement, dated October 28, 2024, by and between the Registrant and GlaxoSmithKline Intellectual Property (No. 3) Limited
License Agreements
Spero Therapeutics, Inc.
Biotechnology
2024
Amendment 2 to Exclusive License Agreement, dated December 20, 2023, by and between the Registrant and GlaxoSmithKline Intellectual Property (No. 3) Limited
License Agreements
Spero Therapeutics, Inc.
Biotechnology
2024
Amendment 1 to Exclusive License Agreement, dated July 4, 2023, by and between the Registrant and GlaxoSmithKline Intellectual Property (No. 3) Limited
License Agreements
Spero Therapeutics, Inc.
Biotechnology
2024
License Agreement, dated June 30, 2021, by and between the Registrant and Pfizer Inc
License Agreements
Spero Therapeutics, Inc.
Biotechnology
DE
2021
Amended and Restated License Agreement, dated January 15, 2021, by and between the Registrant and Everest Medicines II Limited
License Agreements
Spero Therapeutics, Inc.
Biotechnology
MA
2021
License Agreement, dated January 4, 2019, by and between New Pharma License Holdings Limited and Everest Medicines II Limited
License Agreements
Spero Therapeutics, Inc.
Biotechnology
MA
2019
Amended and Restated License Agreement, dated June 28, 2017, by and between Spero Potentiator, Inc. and Northern Antibiotics Oy (Ltd.)
License Agreements
Spero Therapeutics, Inc.
Biotechnology
NY
2017
Assignment and License Agreement, dated May 9, 2016, by and among Spero Trinem, Inc., the Registrant and Vertex Pharmaceuticals Incorporated
License Agreements
Spero Therapeutics, Inc.
Biotechnology
MA
2017
Amended and Restated License Agreement, dated June 28, 2017, by and between Spero Potentiator, Inc. and Northern Antibiotics Oy (Ltd.)
License Agreements
Spero Therapeutics, Inc.
Biotechnology
NY
2017
License Agreement, dated June 14, 2017, by and between the Registrant and Meiji Seika Pharma Co., Ltd., as supplemented by Addendum to License Agreement, dated June 14, 2017
License Agreements
Spero Therapeutics, Inc.
Biotechnology
NY
2017
Assignment and License Agreement, dated May 9, 2016, by and among Spero Trinem, Inc., the Registrant and Vertex Pharmaceuticals Incorporated
License Agreements
Spero Therapeutics, Inc.
Biotechnology
MA
2017